About this trial
The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with health care provider (HCP)-assessed ECOG performance status and overall survival. The purpose is to advance the evidence-base for incorporating objective assessment of Physical Activity (PA) in the context of performance status assessment in advanced cancer patients.
Eligibility criteria
Qualifiers
Diagnosis of any stage I - IV colorectal cancer or recurrent colorectal cancer (Arm 1)
Able to speak, read, and write in English (Pre-pilot phase, Arms 1-4)
Able to provide informed consent (Pre-pilot phase, Arms 1-4, PCS study)
Lives in the Houston area (Harris county or a contiguous county) (Pre-pilot phase)
Disqualifiers
Major surgery in the past 8 weeks (Arms 1 and 4)
Self-reports hypertension that is not being monitored by a physician and is not being managed with either medication, observation, or lifestyle change (Pre-pilot phase, Arms 1-3)
Overt cognitive difficulty demonstrated by not being clearly oriented to time or person or place (Arms 1-4)
Orthopedic, neurologic, or musculoskeletal disability that would interfere with the functional task of standing on a weight scale (Pre-pilot phase, Arm 2)
Trial design
Treatments tested in this trial
- Exercise Intervention
- Health Telemonitoring
- Health Telemonitoring
- Health Telemonitoring
- Health Telemonitoring
- Health Telemonitoring
- Quality-of-Life Assessment
- Questionnaire Administration
- Health Telemonitoring
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator